Arcellx saw the highest growth of 2.99% in patent filings in May and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Arcellx’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Arcellx has been focused on protecting inventions in Japan(JP) with two publications in Q2 2024
The Japan(JP) Patent Office dominates the patent filings and grants with nearly 20% filings and 100% grants. The United States(US), Japan(JP), Australia(AU), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Arcellx is filings its patents. Among the top granted patent authorities, Arcellx has 100% of its grants in Japan(JP).
Roche and Johnson & Johnson could be the strongest competitors for Arcellx
Leukemia related patents lead Arcellx portfolio followed by preleukemia, and breast cancer
Arcellx has highest number of patents in leukemia followed by preleukemia, breast cancer, lung cancer, and ovarian cancer.
For comprehensive analysis of Arcellx's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
